Just when you start thinking this POS is going somewhere, Russ and Joe - the dumbest and laziest managemnt in biotech, screws us again ...

Financing 101 ...
When you have a staph infections drug candidate, sitting on the shelf for 3 years, you find a buyer/partner and monetize it. This is what Nabi did and sold there staph infection vaccine to GSK for $46m!

In Inhibitex, the staph infection drug (Aurexis) will continue to collect dust on the shelves, while Russ&Joe - finance by ... screwing current shareholders and selling new shares at .70-.80c s pop to hedgies and buddies, well below current market price. No wonder the the stock dived!


Nice job Russ&Joe, idiots such! So, what are you gonna tell us on 6th of Nov - the same old crap 'Hang on there, we are making progress!'...Yeah ... right!